Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330

<table>Treatment schema for RTOG 0330 cohort A. Neoadjuvant MAID (Mesna, Doxorubicin, Ifosfamide, DTIC) × 3 cycles, concurrent thalidomide (THAL) and radiation therapy (XRT) × 2 cycles, followed by surgical resection, followed by adjuvant THAL for one year (post-op boost XRT if a positive margin).</table>

Sarcoma

fig1

Figure 1

Figure 1: Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330 